Call Us: 888-488-5750

What does a PBM do? Use this handy guide to explain

We recently saw a well-done explanation of how PBMs interact with the patient’s journey and wanted to share it with our readers.

The short article was created by Pharmaceutical Care Management Association (PCMA), the industry’s representative organization in Washington.

While most of us are deeply familiar with that journey, it’s easy to forget that, to healthcare consumers, that process may not be as clear as it could be.

In the article, the reader is walked through six discreet stages, from doctor’s visit through medicine dispensing and beyond. 

If you regularly come in contact with patients, some of whom may be struggling with who’s who in their healthcare process, you might want to bookmark this short article about what PBMs do for patients for sharing.

And for a deeper dive into how PBMs can do better, check out these articles from VativoRx:

When Drug Negotiation Reaches Part B

For years, Medicare drug price negotiation was mostly discussed as a Part D story. That changed in January, when CMS selected 15 drugs for the third cycle of negotiation, including the first drugs payable under Medicare Part B. Negotiations take place in 2026, and any negotiated prices from this cycle take effect in 2028.

Read More »

TrumpRx: What It Is and What to Watch

TrumpRx.gov has quickly become part of the national conversation on prescription affordability. For provider organizations, the value in tracking TrumpRx isn’t political; it’s operational. Programs like this can influence patient expectations, pricing conversations at the point of care, and the way stakeholders interpret “drug cost” when list, net, and out-of-pocket prices don’t align.

Read More »